KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$10.78 USD
+0.29 (2.76%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.80 +0.02 (0.19%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Brokerage Reports
0 items in cart
KalVista Pharmaceuticals, Inc. [KALV]
Reports for Purchase
Showing records 101 - 105 ( 105 total )
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare - Spotlight on HAE: Takeaways From Our KOL Discussion
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Force Is Strong with This One; Initiating with Buy - $20 PT
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: KalVista Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Force Is Strong with This One; Initiating with Buy - $20 PT
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J